China’s Challenges and Opportunities in the Wake of COVID-19

EXCLUSIVE ARTICLE PACK

China's Challenges and Opportunities in the Wake of COVID-19

What’s Inside:

How China reacted to the deficiencies in primary healthcare exposed by the pandemic

Details on China’s ability to push back digital boundaries

The new ways Chinese pharma companies are finding to complete routine tasks

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA 92008

Forge cross-border partnerships during ChinaBio® Partnering Forum, Delivered Digitally, August 25–27, 2020

August 25–27, 2020
China Standard Time

Terms and Conditions | Privacy Policy

Gain a rare peek into the policies behind the vaccines race in China and the impact COVID-19 has had on its pharmaceutical supply chains, plus much more in this exclusive article pack from Pharma Intelligence.

Brought to you by:

Terms and Conditions | Privacy Policy

DOWNLOAD
YOUR COPY TODAY

Country *

First Name *

Surname *

Email *

Phone Number

Job Title

Company Name

Please tick these boxes if you do not wish to receive marketing information relevant to you from EBD Group

via Email

via Telephone

via Post

Please tick this box if you do not wish to be included on our third party mailing list to receive any related marketing communications from our third party partners